Dual Antiplatelet Therapy Reduced Stroke Risk in High ‐risk Transient Ischemic Attack Patients Assessed by ABCD3‐I Score

ConclusionsHigh ‐risk TIA patients assessed by ABCD3‐I score received the most pronounced clinical benefit from early use of dual antiplatelet therapy in the real‐clinical experience.This article is protected by copyright. All rights reserved.

Source: European Journal of Neurology - November 10, 2018 Category: Neurology Authors: Bo Song, Lulu Pei, Yuan Cao, Pei Chen, Hui Fang, Shilei Sun, Xiao Wang, Xuan Tian, Yinan Guo, Yuming Xu Tags: Original Article Source Type: research